Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
81.30 USD | +1.42% |
|
+0.49% | -18.93% |
07-07 | TD Cowen Initiates ONEOK at Hold With $91 Price Target | MT |
07-03 | JPMorgan Adjusts Price Target on ONEOK to $97 From $94, Maintains Overweight Rating | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.43 | 6.88 | 7.04 | 6.28 | 5.84 | |||||
Return on Total Capital | 6.12 | 7.93 | 8.42 | 7.38 | 6.83 | |||||
Return On Equity % | 9.99 | 24.88 | 27.54 | 23.14 | 16.12 | |||||
Return on Common Equity | 9.97 | 24.86 | 27.52 | 23.14 | 18.1 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 40.18 | 25.9 | 20 | 32.52 | 38.65 | |||||
SG&A Margin | 9.13 | 5.59 | 4.32 | 7.46 | 9.96 | |||||
EBITDA Margin % | 29.59 | 19.3 | 14.87 | 23.87 | 28.56 | |||||
EBITA Margin % | 22.94 | 15.61 | 12.12 | 19.71 | 23.62 | |||||
EBIT Margin % | 22.81 | 15.55 | 12.07 | 19.52 | 23.33 | |||||
Income From Continuing Operations Margin % | 7.17 | 9.07 | 7.69 | 15.04 | 14.34 | |||||
Net Income Margin % | 7.17 | 9.07 | 7.69 | 15.04 | 13.99 | |||||
Net Avail. For Common Margin % | 7.16 | 9.06 | 7.69 | 15.04 | 13.98 | |||||
Normalized Net Income Margin | 10.42 | 7.49 | 5.99 | 10.17 | 11.69 | |||||
Levered Free Cash Flow Margin | -12.74 | 6.35 | 2.81 | 6.96 | 6.64 | |||||
Unlevered Free Cash Flow Margin | -7.52 | 9.12 | 4.69 | 10.02 | 10.58 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.38 | 0.71 | 0.93 | 0.52 | 0.4 | |||||
Fixed Assets Turnover | 0.45 | 0.86 | 1.14 | 0.67 | 0.55 | |||||
Receivables Turnover (Average Receivables) | 10.26 | 14.56 | 15.05 | 10.92 | 10.77 | |||||
Inventory Turnover (Average Inventory) | 11.64 | 25.75 | 30.84 | 17.44 | 19.19 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.39 | 0.75 | 0.83 | 0.9 | 0.9 | |||||
Quick Ratio | 1.01 | 0.5 | 0.57 | 0.59 | 0.65 | |||||
Operating Cash Flow to Current Liabilities | 1.41 | 0.8 | 0.95 | 1.28 | 1.04 | |||||
Days Sales Outstanding (Average Receivables) | 35.67 | 25.06 | 24.24 | 33.42 | 34 | |||||
Days Outstanding Inventory (Average Inventory) | 31.43 | 14.17 | 11.84 | 20.93 | 19.07 | |||||
Average Days Payable Outstanding | 70.97 | 30.03 | 27.43 | 43.96 | 51.15 | |||||
Cash Conversion Cycle (Average Days) | -3.87 | 9.2 | 8.65 | 10.39 | 1.92 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 241.05 | 231.12 | 211.33 | 132.03 | 145.9 | |||||
Total Debt / Total Capital | 70.68 | 69.8 | 67.88 | 56.9 | 59.33 | |||||
LT Debt/Equity | 240.66 | 213.53 | 196.85 | 128.96 | 140.84 | |||||
Long-Term Debt / Total Capital | 70.56 | 64.49 | 63.23 | 55.58 | 57.27 | |||||
Total Liabilities / Total Assets | 73.82 | 74.54 | 73.36 | 62.76 | 65.45 | |||||
EBIT / Interest Expense | 2.73 | 3.51 | 4 | 3.98 | 3.69 | |||||
EBITDA / Interest Expense | 3.57 | 4.38 | 4.95 | 4.87 | 4.52 | |||||
(EBITDA - Capex) / Interest Expense | 0.49 | 3.43 | 3.17 | 3.03 | 3.05 | |||||
Total Debt / EBITDA | 5.72 | 4.33 | 4.1 | 5.16 | 5.21 | |||||
Net Debt / EBITDA | 5.52 | 4.28 | 4.04 | 5.08 | 5.09 | |||||
Total Debt / (EBITDA - Capex) | 41.7 | 5.53 | 6.4 | 8.29 | 7.73 | |||||
Net Debt / (EBITDA - Capex) | 40.2 | 5.47 | 6.3 | 8.16 | 7.56 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -15.96 | 93.63 | 35.35 | -21.04 | 22.75 | |||||
Gross Profit, 1 Yr. Growth % | 1.65 | 24.81 | 4.51 | 28.39 | 45.91 | |||||
EBITDA, 1 Yr. Growth % | 6.16 | 26.34 | 3.43 | 22.92 | 46.82 | |||||
EBITA, 1 Yr. Growth % | 2.27 | 31.75 | 4.07 | 23.68 | 47.07 | |||||
EBIT, 1 Yr. Growth % | 2.34 | 31.95 | 4.09 | 22.94 | 46.68 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -52.07 | 144.73 | 14.84 | 54.41 | 17.04 | |||||
Net Income, 1 Yr. Growth % | -52.07 | 144.73 | 14.84 | 54.41 | 14.14 | |||||
Normalized Net Income, 1 Yr. Growth % | -14.05 | 39.28 | 8.08 | 27.82 | 41.16 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -53.78 | 136.09 | 14.63 | 42.71 | -5.66 | |||||
Accounts Receivable, 1 Yr. Growth % | -0.64 | 73.75 | 6.28 | 11.29 | 36.42 | |||||
Inventory, 1 Yr. Growth % | -26.78 | 56.58 | -0.03 | 35.46 | 17.06 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.85 | 0.8 | 3.22 | 63.88 | 40.71 | |||||
Total Assets, 1 Yr. Growth % | 5.81 | 2.35 | 3.21 | 81.57 | 44.74 | |||||
Tangible Book Value, 1 Yr. Growth % | 0.01 | -0.32 | 9.31 | 77.95 | -42.19 | |||||
Common Equity, 1 Yr. Growth % | -2.95 | -0.45 | 7.96 | 153.83 | 3.35 | |||||
Cash From Operations, 1 Yr. Growth % | -2.45 | 34.08 | 14.13 | 52.13 | 10.56 | |||||
Capital Expenditures, 1 Yr. Growth % | -42.95 | -68.26 | 72.5 | 32.7 | 26.71 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -54.84 | -196.58 | -41.1 | 74.08 | 17 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -69.43 | -334.8 | -31.09 | 56.88 | 29.62 | |||||
Dividend Per Share, 1 Yr. Growth % | 3.74 | 0 | 0.53 | 2.53 | 3.76 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -17.64 | 27.56 | 61.89 | 3.38 | -1.55 | |||||
Gross Profit, 2 Yr. CAGR % | 4.04 | 12.64 | 14.21 | 15.85 | 36.87 | |||||
EBITDA, 2 Yr. CAGR % | 6.06 | 15.81 | 14.31 | 14.52 | 34.34 | |||||
EBITA, 2 Yr. CAGR % | 3.48 | 16.08 | 17.07 | 15.62 | 34.87 | |||||
EBIT, 2 Yr. CAGR % | 3.53 | 16.21 | 17.16 | 15.3 | 34.29 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -27.16 | 8.3 | 67.64 | 33.14 | 34.43 | |||||
Net Income, 2 Yr. CAGR % | -27.06 | 8.3 | 67.64 | 33.14 | 32.76 | |||||
Normalized Net Income, 2 Yr. CAGR % | -2.97 | 9.41 | 22.68 | 20.4 | 34.33 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -28.56 | 4.46 | 64.51 | 27.9 | 16.03 | |||||
Accounts Receivable, 2 Yr. CAGR % | 0.56 | 31.39 | 35.89 | 8.75 | 23.22 | |||||
Inventory, 2 Yr. CAGR % | -7.95 | 7.07 | 25.11 | 16.4 | 13.47 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 14.19 | 2.81 | 2.01 | 29.79 | 52.1 | |||||
Total Assets, 2 Yr. CAGR % | 12.51 | 4.07 | 2.78 | 36.89 | 62.11 | |||||
Tangible Book Value, 2 Yr. CAGR % | -3.11 | -0.15 | 4.39 | 39.47 | 1.43 | |||||
Common Equity, 2 Yr. CAGR % | -4.17 | -1.71 | 3.67 | 65.54 | 61.97 | |||||
Cash From Operations, 2 Yr. CAGR % | -6.81 | 14.37 | 23.7 | 31.77 | 29.69 | |||||
Capital Expenditures, 2 Yr. CAGR % | 1.25 | -57.45 | -26 | 51.27 | 29.67 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 45.42 | -33.96 | -23.59 | 7.42 | 42.72 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 70.5 | -15.27 | 29.1 | 7.81 | 42.6 | |||||
Dividend Per Share, 2 Yr. CAGR % | 5.9 | 1.86 | 0.27 | 1.53 | 3.14 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -11.14 | 9.51 | 30.11 | 27.43 | 9.47 | |||||
Gross Profit, 3 Yr. CAGR % | 9.2 | 10.55 | 9.86 | 18.76 | 25.11 | |||||
EBITDA, 3 Yr. CAGR % | 11.99 | 12.43 | 11.82 | 18.33 | 24.41 | |||||
EBITA, 3 Yr. CAGR % | 11.73 | 12.16 | 12.29 | 20.74 | 25.28 | |||||
EBIT, 3 Yr. CAGR % | 11.84 | 12.25 | 12.38 | 20.58 | 24.93 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 1.07 | 9.09 | 10.44 | 63.1 | 27.54 | |||||
Net Income, 3 Yr. CAGR % | 16.47 | 9.2 | 10.44 | 63.1 | 26.48 | |||||
Normalized Net Income, 3 Yr. CAGR % | 24.88 | 9.46 | 8.99 | 26.38 | 26.96 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 3.23 | 6.41 | 7.75 | 56.89 | 15.56 | |||||
Accounts Receivable, 3 Yr. CAGR % | -11.64 | 20.66 | 22.42 | 27.13 | 17.28 | |||||
Inventory, 3 Yr. CAGR % | -4.99 | 9.88 | 4.65 | 28.49 | 8.79 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 14.89 | 9.54 | 2.95 | 19.3 | 33.48 | |||||
Total Assets, 3 Yr. CAGR % | 11.06 | 9.02 | 3.78 | 24.25 | 39.46 | |||||
Tangible Book Value, 3 Yr. CAGR % | 5.13 | -2.19 | 2.91 | 24.7 | 3.99 | |||||
Common Equity, 3 Yr. CAGR % | 3.01 | -2.95 | 1.41 | 39.73 | 41.48 | |||||
Cash From Operations, 3 Yr. CAGR % | 13.02 | 5.21 | 14.29 | 32.53 | 24.29 | |||||
Capital Expenditures, 3 Yr. CAGR % | 62.42 | -31.22 | -32.15 | -10.1 | 42.6 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 61 | 26.88 | -36.12 | 4.58 | 10.53 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 4.43 | 89.69 | -20.64 | 41.13 | 14.64 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.16 | 3.89 | 1.41 | 1.01 | 2.27 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 1.93 | 13.14 | 12.96 | 7.02 | 16.38 | |||||
Gross Profit, 5 Yr. CAGR % | 10.09 | 12.05 | 11.18 | 12.64 | 19.96 | |||||
EBITDA, 5 Yr. CAGR % | 12.08 | 13.87 | 13.09 | 13.44 | 21.08 | |||||
EBITA, 5 Yr. CAGR % | 12.53 | 14.92 | 14.06 | 13.74 | 21.74 | |||||
EBIT, 5 Yr. CAGR % | 12.65 | 15.04 | 14.17 | 13.67 | 21.6 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 9.73 | 15 | 23.75 | 18.15 | 19.47 | |||||
Net Income, 5 Yr. CAGR % | 20.13 | 33.62 | 34.74 | 18.22 | 18.87 | |||||
Normalized Net Income, 5 Yr. CAGR % | 20.27 | 43.84 | 24.02 | 13.72 | 19.64 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 3.58 | 14.94 | 24.38 | 14.54 | 10.99 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.92 | 10.57 | 4.96 | 15.75 | 22.74 | |||||
Inventory, 5 Yr. CAGR % | 12.62 | 23.65 | 6.07 | 12.44 | 8.1 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.25 | 9.08 | 9.55 | 17.23 | 20.24 | |||||
Total Assets, 5 Yr. CAGR % | 8.36 | 7.92 | 7.67 | 19.41 | 24.05 | |||||
Tangible Book Value, 5 Yr. CAGR % | 50.54 | 45.1 | 4.83 | 12.73 | 2.31 | |||||
Common Equity, 5 Yr. CAGR % | 78.25 | 99.84 | 3.27 | 20.16 | 22.3 | |||||
Cash From Operations, 5 Yr. CAGR % | 13.18 | 13.48 | 17.18 | 15.12 | 20.22 | |||||
Capital Expenditures, 5 Yr. CAGR % | 13.06 | 2.21 | 18.59 | -5.72 | -12.09 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 18.81 | 25.33 | 19.23 | 19.05 | -9.79 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 26.39 | 18.96 | 13.24 | 51.62 | 1.79 | |||||
Dividend Per Share, 5 Yr. CAGR % | 8.92 | 8.74 | 5.51 | 2.94 | 2.1 |
- Stock Market
- Equities
- OKE Stock
- Financials Oneok, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition